Table 3.
Serum levels of endocan, IL-1, TNF-α, VEGF, hs-CRP in patients with SLE and healthy control subjects.
Molecule | SLE patients, n = 36 | Healthy controls n = 23 |
---|---|---|
Endocan | 122.2 (96.15–164.70) pg/ml 128 ±49.2 pg/ml |
54 (29–85) pg/ml 64.3 ±54.5 pg/ml |
IL-1 β | 1.5 (1.3–1.75) pg/ml 3 ±6.6 pg/ml |
1.7 (1.3–2) pg/ml 1.8 ±0.8 pg/ml |
TNF-α | 6.4 (5.5–7.6) pg/ml 7 ±3.1 pg/ml |
5.3 (0.9–2) pg/ml 5.3 ±1.2 pg/ml |
VEGF | 274.45 (168.5–546.86) pg/ml 421 ±342.3 pg/ml |
256.9 (160–456) pg/ml 338 ±258.2 pg/ml |
hs-CRP | 4.1 (1.4–10.5) μg/ml 6 ±5.1 μg/ml |
0.5 (0.1–3) μg/ml 2.2 ±3.3 μg/ml |
Results are displayed as median with the range and mean ± standard deviation.